Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) EBT (2019 - 2025)

Historic EBT for Legend Biotech (LEGN) over the last 7 years, with Q3 2025 value amounting to -$39.1 million.

  • Legend Biotech's EBT rose 6767.78% to -$39.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$263.0 million, marking a year-over-year decrease of 3228.0%. This contributed to the annual value of -$158133.0 for FY2024, which is 9996.96% up from last year.
  • As of Q3 2025, Legend Biotech's EBT stood at -$39.1 million, which was up 6767.78% from -$124.8 million recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's EBT ranged from a high of $40511.0 in Q4 2024 and a low of -$407.2 million during Q4 2021
  • In the last 5 years, Legend Biotech's EBT had a median value of -$91.6 million in 2021 and averaged -$100.2 million.
  • Per our database at Business Quant, Legend Biotech's EBT tumbled by 3385875.4% in 2022 and then soared by 12759.38% in 2024.
  • Over the past 5 years, Legend Biotech's EBT (Quarter) stood at -$407.2 million in 2021, then skyrocketed by 66.67% to -$135.7 million in 2022, then skyrocketed by 99.89% to -$146812.0 in 2023, then soared by 127.59% to $40511.0 in 2024, then plummeted by 96550.35% to -$39.1 million in 2025.
  • Its EBT was -$39.1 million in Q3 2025, compared to -$124.8 million in Q2 2025 and -$99.1 million in Q1 2025.